Susan Ingle
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Neutropenia and Cancer Infections, Plant-based Medicinal Research, Breast Cancer Treatment Studies
Most-Cited Works
- → Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping(2012)158 cited
- → Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel(2014)110 cited
- → CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen(2010)91 cited
- → Tight glycaemic control: a survey of intensive care practice in large English hospitals(2005)85 cited
- → A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities(2015)32 cited
- → Hypoglycaemia? So what!(2006)22 cited
- → The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study(2016)9 cited
- Read to Write : An Intergrated course for Nonnative Speakers of English(1997)
- → A pharmacodynamic biomarker study of vistusertib (AZD2014), an mTORC1/2 inhibitor, given prior to radical prostatectomy (CANCAP02).(2018)5 cited
- → CANCAP02: A study into the pharmacodynamic biomarker effects of vistusertib (AZD2014), an mTORC1/2 inhibitor, given prior to radical prostatectomy (RP).(2017)1 cited